Skip to main content

iNO delivery & monitoring system

Inhaled nitric oxide (iNO or KINOX™) delivery and monitoring system to protect vulnerable lives.

or more information

SoKINOX™ is our user-friendly iNO delivery & monitoring device specifically developed to bring easy-to-use inhaled nitric oxide (iNO or KINOX™) to the next level and help your patients inspire breath into life.

KINOX™ is a precise nitric oxide blend for the treatment of term and near-term (>=34 weeks) neonates with a hypoxic respiratory failure, associated with clinical or echocardiographic evidence of pulmonary hypertension.  It improves the oxygenation and reduces the need for extracorporeal membrane oxygenation.

KINOX™ is a selective pulmonary vasodilator for the treatment of neonates developed by Air Liquide Healthcare and characterized by:

  • A rapid and reversible action1
  • A selective vasodilator which redistributes pulmonary blood flow1
  • Reduces the oxygenation index (OI) and increases PaO21
  • Absence of systemic effect2
  • Reduction in the shunt effect (V/Q) by acting only on ventilated alveoli2

Key features

Safety features

  • Automatic cylinder switch 
  • Automatic emergency dosing
  • Backup system with manual mode
  • Automatic purging of device and cylinders
  • User configurable default parameters and alarm level

Innovative features

  • Gas supply calculator
  • JetSense, AutoSense and Constant Rate settings
  • Flow and trend waveforms display 
  • Two flow sensors available
  • High range sensor calibration 
  • Event logging and electronic charting compatibility


  • SoKINOX™ functions with all ventilation modes, for all types of patients, thanks to its reliable flow sensor
  • Features a quick pre-use check to facilitate a rapid and error-free response in emergencies

Intuitive controls

  • Large colour touchscreen with easy-to-use interface provides clear and organized information, making the device very intuitive and user-friendly


  • Its compact design includes a hand-bagging KINOX™ administration system in case of emergency, transport, or the need for alveolar recruitment


Technical Support

Evolving to inspire better care

SoKINOX™ brings inhaled Nitric Oxide (iNO) therapy to the next level:

24/7 clinical support

Our knowledgeable in-house clinical affairs team is dedicated to Canadian healthcare professionals, supporting the delivery of NO using SoKINOX™ with clinical application expertise and training.

Continuous improvement

SoKINOX™ has been designed and developed incorporating important human factor principles and testing. The development team is continuously improving the device and its user interface.

Delivering excellence

SoKINOX™ delivers an innovative and intuitive inhaled Nitric Oxide therapy dosing and monitoring device with a simplified business model. 

Related resources


  1. KINOX™ Product Monograph, Air Liquide Healthcare America Corporation, 2016 - Date of Revision:

    May 19, 2022
  2. Fumito Ichinose: A selective Pulmonary Vasodilator: Current uses and therapeutic potential. Circulation 2004:109:3106-3111.
  3. The Franco-Belgium Collaborative NO Trial Group. Early compared to delayed inhaled nitric oxide in moderately hypoxemic neonates with respiratory failure: a randomized controlled trial. Lancet 1999:354:1066-1071.
  4. The Neonatal inhaled Nitric Oxide Study Group. Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N Eng J Med 1997: 336: 597-604.
  5. Clark. R.H et al. Low dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. NEJM volume 342, number 7.
  6. Clark. R.H et al. Low dose nitric oxide therapy for persistent pulmonary hypertension: 1 year followup. J Perinatol 2003:23:300-303.

Do you need pricing or more information?

Our team will listen to your needs and answer your questions, to help identify the right equipment and services for your facility.

Write us

Leave us a message and we will contact you in less than 48 hours.

Talk to us

Whenever you need assistance, please call our toll-free number (24/7).

Visit us

Air Liquide Healthcare
6990 Creditview Road, Unit 6
Mississauga, ON L5N 8R9

Why choose us

  • Full-scope medical gases provider
    We are involved from production to patient therapy, and know medical gases intimately

  • Reliability
    You can depend on us to provide you with the right equipment and services to meet your facility's needs

  • Innovation
    Innovation is our vision: we prioritize quality of care through patient-centric products and services

  • Safety
    Ensuring the safety of your patients and staff is our top priority - our emphasis is on safety, compliance and risk management

  • Experienced
    We are owned by Air Liquide Group, the largest supplier of industrial, medical & specialty gases, found on every continent in the world

  • Coast-to-coast service network
    Our fill plants are widespread to shorten response-time and ensure supply chain reliability

  • Accreditation and regulation
    We help you ensure your facility's medical equipment is serviced and fully compliant with Canadian standards

  • Customized portfolio
    We supply a complete range of high-quality specialty gases, including mixtures used in specific applications to suit your needs